1. Home
  2. COE vs VRCA Comparison

COE vs VRCA Comparison

Compare COE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 51Talk Online Education Group

COE

51Talk Online Education Group

HOLD

Current Price

$20.00

Market Cap

101.0M

Sector

Real Estate

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.22

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COE
VRCA
Founded
2011
2013
Country
Singapore
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.0M
88.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
COE
VRCA
Price
$20.00
$5.22
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
13.6K
30.4K
Earning Date
06-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$14.66
$3.28
52 Week High
$56.13
$9.82

Technical Indicators

Market Signals
Indicator
COE
VRCA
Relative Strength Index (RSI) 59.88 44.53
Support Level $15.16 $4.25
Resistance Level $28.40 $6.29
Average True Range (ATR) 1.17 0.43
MACD 0.40 0.01
Stochastic Oscillator 83.26 48.72

Price Performance

Historical Comparison
COE
VRCA

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in geographical areas: Asia-Pacific region; and Other areas, of which it derives maximum revenue from Asia-Pacific.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: